|

Intratumoral MMR Injection Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of Arkansas1

Indications

  • Non Metastatic Pancreatic Cancer1
  • Borderline Resectable/Unresectable Pancreatic Cancer1
  • Cancer1

Little Rock, Arkansas1 trial

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

University of Arkansas for Medical Sciences

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.